Scientific Program

  • HOME
  • PROGRAM
  • Scientific Program

April 11 (Thu)

JS MIN Memorial Lecture

Date & Time April 11 (Thu), 10:00-10:30 Venue Room A
Chairs TBD
Speaker Progress of systematic lymph node dissection, its difficult past for the approval and coming future
Keiichi Maruyama, University of Health and Welfare Sanno Medical Center, Japan

Symposium 1

Function Preserving Surgery for Proximal Gastric Cancer

Total gastrectomy is the standard surgical treatment for proximal gastric cancer. However, function preserving surgery can be considered in special situations. This session will introduce various function preserving surgeries and their outcomes.

Date & Time April 11 (Thu), 10:50-12:20 Venue Room A
Chairs TBD
Speaker
  1. Nutritional outcome of Near-total gastrectomy for proximal gastric cancer
    TBD
  2. Proximal gastrectomy with double-flap technique
    Masahiko Nishizaki, Cancer Institute Hospital, Japan
  3. Functional outcome of proximal gastrectomy with double tract reconstruction
    TBD
  4. Pylorus preserving gastrectomy for proximal gastric cancer
    TBD

Symposium 2

Global Gastric Cancer Symposium

TBD

Date & Time April 11 (Thu), 10:50-12:20 Venue Room B
Chairs TBD
Speaker
  1. Experience of gastric treatment in Mogolia
    Enkh-Amgalan. TS, United Family Intermed Hospital, Mongolia
  2. Experience of gastric treatment in India
    S.M. Chandramohan, Madras Medical College, India
  3. Laparoscopic gastrectomy for gastric cancer: A single center experience at University Medical Center, Hochiminh city, Vietnam
    Vo Duy Long, University of Medicine & Pharmacy of HCM City, Korea
  4. Gastric cancer surgery in Russia: where we are now and where we are going to
    Alexey Karachun, N.N. Petrov National Medical Research Center of Oncology, Russia
  5. Evolution of Gastric Cancer Treatment in Turkey, questing the best and beyond
    Ali Guner, Karadeniz Technical University, Turkey

Symposium 3

Up to date of Enhanced Recovery after Surgery (ERAS) in Gastric Cancer Surgery

TBD

Date & Time April 11 (Thu), 10:50-12:20 Venue Room C
Chairs TBD
Speaker
  1. Overview and current status of ERAS in gastric cancer surgery
    TBD
  2. How to implement ERAS in clinical practice
    Sang Woong Lee, Osaka Medical School, Japan
  3. Perioperative nutrition for patient undergoing gastric cancer surgery in ERAS
    TBD
  4. Perspective of anesthesiologist to ERAS
    TBD

Education Session 1

TBD

Date & Time April 11 (Thu), 10:50-12:20 Venue Room D
Chairs TBD
Speaker
  1. Pathologic classification of Gastric cancer
    TBD
  2. Endoscopic and EUS findings for gastric cancer
    TBD
  3. Initial considerations for radiologic evaluation in gastric cancer
    TBD
  4. Standard endoscopic treatment for gastric cancer
    TBD

Symposium 4

Issues of Treatment for Type Ⅱ GEJ Adenocarcinoma

Type 2 gastroesophageal junction (GEJ) adenocarcinoma is a distinctive disease entity requiring characteristic treatment strategies. This session will cover surgical approaches, management of complications, and the current status of neoadjuvant chemotherapy.

Date & Time April 11 (Thu), 13:20-14:50 Venue Room A
Chairs TBD
Speaker
  1. Overview of type II GEJ cancer
    TBD
  2. Transhiatal approach versus transthoracic approach
    Hitoshi Katai, National Cancer Center Japan, Japan
  3. Management of postoperative complication following GEJ cancer surgery
    Simon Law, The University of Hong Kong, Hong Kong
  4. Chemotherapy vs chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer: final results of the CRITICS study
    Edwin Jansen, Netherlands Cancer Institute, Netherlands

Symposium 5

Journal of Gastric Cancer Session

The Journal of Gastric cancer was indexed on the SCIE in 2018 with an IF of 1.4. In this session, the history of the JGC including the efforts of SCIE registration as well as the prospects for the future evolution of this journal will be discussed.

Date & Time April 11 (Thu), 13:20-14:50 Venue Room B
Chairs TBD
Speaker
  1. History of JGC and its registration on SCIE
    TBD
  2. How to raise impact factor
    TBD
  3. Comments for further evolution (from Korea)
    TBD
  4. Comments for further evolution (from outside)
    Yuko Kitagawa, Keio University School of Medicine, Japan

Symposium 6

Recent Updates on Immunotherapy

Immunotherapy is now one of the most important issues in managing cancer patients. This session will deal with immunotherapy, from the concept to clinical application, focusing on the latest updates to research and treatment in this field.

Date & Time April 11 (Thu), 13:20-14:50 Venue Room C
Chairs TBD
Speaker
  1. The history and overview of immunotherapy for cancer
    TBD
  2. Immune landscape by multiplex immunohistochemistry
    TBD
  3. Pathologic interpretation of immune biomarkers in gastric cancer
    TBD
  4. Update on clinical trials in gastric cancer immunotherapy
    TBD

Education Session 2

TBD

Date & Time April 11 (Thu), 13:20-14:50 Venue Room D
Chairs TBD
Speaker
  1. Lymph node dissection: overall concept
    TBD
  2. Standard lymph node dissection for open Distal gastrectomy
    TBD
  3. Standard lymph node dissection for open Total gastrectomy
    TBD
  4. Standard lymph node dissection for Lap. Distal gastrectomy
    TBD

Video Symposium 1

How I do it: Lymph Node Dissection for No 11d and 10 (With or without splenectomy)

Dissection of lymph node stations 11d and 10, which are indicated for advanced gastric cancer located in the upper third of the greater curvature side, is one of the most challenging procedures in laparoscopic surgery. Selected world-best surgeons will share their techniques either by splenectomy or by meticulous dissection around the vessels without splenectomy.

Date & Time April 11 (Thu), 16:30-18:00 Venue Room A
Chairs TBD
Speaker
  1. How I do it
    TBD
  2. How I do it
    TBD
  3. How I do it
    Chang-ming Huang, Fujian Medical University, China
  4. How I do it
    Hirokazu Noshiro, Saga University Faculty of Medicine, Japan

Symposium 7

Korea-Germany Session

TBD

Date & Time April 11 (Thu), 16:30-18:00 Venue Room B
Chairs TBD
Speaker
  1. New German S3-guidelines for gastric and GEJ cancer
    Hans-J. Meyer, German Society of Surgery, Germany
  2. Multidisciplinary approach for GEJ cancer
    TBD
  3. Surgical treatment of type II GEJ cancer
    TBD

Symposium 8

Precision Medicine Based on Molecular Classification for Gastric Cancer

Thanks to advanced technology, disease classification in cancer has moved towards molecular based data involving DNA, RNA and protein. To achieve successful individual therapies and applications, numerous challenges have been tried in the field of gastric cancer research as well. This session will focus on the latest results of high through-put molecular analysis for gastric cancer and its application for precision medicine in the clinical setting.

Date & Time April 11 (Thu), 16:30-18:00 Venue Room B
Chairs TBD
Speaker
  1. Transcriptome-based molecular classification of gastric cancer
    Hans-J. Meyer, German Society of Surgery, Germany
  2. Molecular characterization related to immunotherapy response in metastatic gastric cancer
    TBD
  3. Molecular prediction of prognosis for adjuvant chemotherapy in resectable gastric cancer
    TBD
  4. Clinical application of molecular-based gastric cancer organoid
    Leung Suet Yi, The University of Hong-Kong, HongKong

Video Symposium 2

Unique Surgical Tips for Laparoscopic Gastrectomy

Please join in the Video Contest (Click)

Date & Time April 11 (Thu), 16:30-18:00 Venue Room D
Chairs TBD
Speaker
  1. Various techniques of liver retraction for gastrectomy
    TBD
  2. Various techniques of mesenteric defect closure
    TBD
  3. Various techniques of stapler entry hole closure
    TBD
  4. Optimal placement of drainage after gastrectomy
    TBD

April 12 (Fri)

Symposium 9

Application of Artificial Intelligence in the Medical Field

Artificial intelligence (AI) is currently applied in various fields of medicine. This session covers the current clinical application of AI in gastric cancer diagnosis.

Date & Time April 12 (Fri), 08:30-10:00 Venue Room A
Chairs TBD
Speaker
  1. Artificial intelligence application in Medical field: General concept
    TBD
  2. Computer-aided diagnosis for identifying and delineating early gastric cancers in magnifying narrow-band imaging
    Noriya Uedo, Osaka International Cancer Institute, Japan
  3. Application of artificial intelligence in abdominal radiology field
    TBD
  4. Practical application of digital pathology and deep learning
    TBD

Symposium 10

Primary and Secondary Prevention of Gastric Cancer

Gastric cancer screening programs have contributed to reducing mortality in countries which run the program. Updated screening strategies and epidemiological study results will be discussed in this session for primary and secondary prevention of gastric cancer.

Date & Time April 12 (Fri), 08:30-10:00 Venue Room B
Chairs TBD
Speaker
  1. Update of risk factors of gastric cancer development
    TBD
  2. Gastric cancer screening: when and how
    TBD
  3. Gastric cancer in young age and prophylactic gastrectomy
    TBD
  4. Helicobacter eradication after gastric cancer treatment
    TBD

Symposium 11

Neoadjuvant Treatment for Gastric Cancer

Neoadjuvant chemotherapy (NAC) has been rapidly introduced in western guidelines for locally advanced gastric cancer patients who received adequate surgery with an extended (D2) lymph node dissection and recently, active multicenter RCTs are being conducted in the East and West. As laparoscopic surgery progresses, studies are underway to apply it after neoadjuvant chemotherapy in gastric cancer.

Date & Time April 12 (Fri), 08:30-10:00 Venue Room C
Chairs TBD
Speaker
  1. Indication of neoadjuvant treatment for gastric cancer for locally advanced gastric cancer
    TBD
  2. Multicenter trial of neoadjuvant chemotherapy for GEJ cancer (FLOT trial)
    TBD
  3. Multicenter trial of neoadjuvant chemotherapy for AGC (Eastern experience)
    TBD
  4. Choice of surgical options in neoadjuvant treatment
    TBD

Education Session 3

TBD

Date & Time April 12 (Fri), 08:30-10:00 Venue Room D
Chairs TBD
Speaker
  1. Standard lymph node dissection for Lap. Total gastrectomy
    TBD
  2. Anastomosis after distal gastrectomy
    TBD
  3. Anastomosis after Total gastrectomy
    TBD
  4. Overall of post-operative complications (Excluding leakage)
    TBD

JP KIM Memorial Lecture

Date & Time April 12 (Fri), 12:00-12:30 Venue Room A
Chairs TBD
Speaker Lessons learned from 30 years of Minimally Invasive Upper GI Surgery
Bernald Dallemange, Institute for Research against Cancer of the Digestive System (IRCAD), France

Symposium 12

Korean Gastric Cancer Treatment Guideline

Introduction of development and comparisons of clinical applications of gastric cancer treatment guidelines in different regions of the world

Date & Time April 12 (Fri), 14:00-15:30 Venue Room A
Chairs TBD
Speaker
  1. Genenral concept of Guideline
    TBD
  2. Development of NCCN guideline
    TBD
  3. Development of JGCA guideline
    Takeshi Sano, The Cancer Institute Hospital of JFCR, Japan
  4. Development of KGCA guideline
    TBD

Symposium 13

New Evidence in ESD: Indication and Evaluation of Curability

This session will cover new evidence on indications and evaluations of curability of ESD for early gastric cancer.

Date & Time April 12 (Fri), 14:00-15:30 Venue Room B
Chairs TBD
Speaker
  1. ESD for clinically submucosal invasive EGC
    TBD
  2. Optimal treatment strategy for non-curative ESD
    TBD
  3. Treatment outcomes of laparoscopic gastrectomy after non-curative ESD
    TBD
  4. Treatment strategy after non-curative ESD in elderly patients
    Sekiguchi Masau, National Cancer Center, Japan

Symposium 14

Surgical Role for Metastatic Gastric Cancer

TBD

Date & Time April 12 (Fri), 14:00-15:30 Venue Room C
Chairs TBD
Speaker
  1. The role of surgical oncologists in multidisciplinary treatment of metastatic gastric carcinoma
    TBD
  2. Proper decision of surgical approach for hepatic metastasis of gastric carcinoma
    TBD
  3. Conversion surgery for metastatic gastric carcinoma
    Kazuhiro Yoshida, Gifu University School of Medicine, Japan
  4. Multimodal treatment for peritoneal metastasis in gastric carcinoma
    TBD

Education Session 4

TBD

Date & Time April 12 (Fri), 14:00-15:30 Venue Room D
Chairs TBD
Speaker
  1. Diagnosis and management for anastomosis leakage
    TBD
  2. Management for long-term problems in in gastrectomized patients (Nutrition, Dumping, IDA, Vit B12)
    TBD
  3. Standard adjuvant Chemotherapy
    TBD
  4. Overall concept of chemotherapy and toxicity
    TBD

Symposium 15

Modern Approach to Achalasia

KINGCA covers not only gastric cancer, but also benign gastrointestinal diseases. This session will focus on achalasia, a rare benign esophageal disease. As well as surgical and endoscopic treatment for achalasia, diagnostic evaluation and choice of therapeutic method will be reviewed.

Date & Time April 12 (Fri), 16:30-18:00 Venue Room B
Chairs TBD
Speaker
  1. Evaluation of patients with achalasia (HRM, EUS..)
    TBD
  2. Who should get what treatment?
    TBD
  3. Endoscopic therapeutic options for achalasia
    TBD
  4. Heller myotomy
    TBD

Symposium 16

Update for Treatment of Peritoneal Carcinomatosis

There is no standard treatment for peritoneal carcinomatosis (PC) from gastric cancer. Multidisciplinary treatment including neoadjuvant intraperitoneal-systemic chemotherapy (NIPS), peritonectomy, hyperthermic intraperitoneal chemoperfusion (HIPEC) and early postoperative intraperitoneal chemotherapy has been developed. As taxanes are the most appropriate drugs for intraperitoneal administration, the development of repeated intraperitoneal chemotherapy using taxanes for gastric cancer peritoneal metastasis-either alone or in combination with systemic chemotherapy-has taken place over the past decade.

Date & Time April 12 (Fri), 16:30-18:00 Venue Room C
Chairs TBD
Speaker
  1. Overview of peritoneal carcinomatosis in gastric cancer
    Yutaka Yonemura, Kishiwada Tokushukai Hospital, Kusatsu General Hospital, Japan
  2. Optimal agent for IP chemotherapy for peritoneal carcinomatosis
    TBD
  3. Various types of approach for peritoneal carcinomatosis
    TBD
  4. Recent treatment outcomes for peritoneal carcinomatosis
    TBD

Symposium 17 (KLASS sy 1)

Function-preserving Gastrectomy: Update Session

Preliminary results of KLASS-04 and 05 will be presented and technical tips for function-preserving gastrectomy will be introduced

Date & Time April 12 (Fri), 16:30-18:00 Venue Room D
Chairs TBD
Speaker
  1. Preliminary results of KLASS-04
    TBD
  2. Intra-corporeal anastomosis after pylorus-reserving gastrectomy
    TBD
  3. Preliminary results of KLASS-05
    TBD
  4. Technical consideration for double tract reconsturction
    TBD

April 13 (Sat)

Video Symposium 3

How to Establish Robotic Gastrectomy - Intracorporal Anastomosis Technique

To perform a high-quality robotic gastrectomy, various types of anastomosis techniques should be well established. This session will highlight robotic techniques to improve the quality of gastric cancer surgery focusing on intracorporeal anastomoses during robotic gastrectomy.

Date & Time April 13 (Sat), 08:30-10:00 Venue Room A
Chairs TBD
Speaker
  1. Anastomosis after robotic subtotal gastrectomy using endolinear stapler
    Yanghee Woo, City of Hope National, USA
  2. Anastomosis after robotic total gastrectomy using endolinear stapler
    TBD
  3. Anastomosis after robotic total gastrectomy using endolinear stapler
    TBD
  4. Anastomosis after robotic gastrectomy using robotic stapler
    Ichiro Uyama, Fujita Health University, Japan

Symposium 18

Everything We Must Know about Sleeve Gastrectomy

KINGCA also covers bariatric and metabolic surgery. These surgeries are now becoming important socio-economic issues since they have been covered by public insurance in Korea. We will have lectures and discussion on sleeve gastrectomy, the most commonly performed bariatric surgery.

Date & Time April 13 (Sat), 08:30-10:00 Venue Room B
Chairs TBD
Speaker
  1. Metabolic role of sleeve gastrectomy
    TBD
  2. Technical consideration of sleeve gastrectomy; step by step
    TBD
  3. Management of leaks after sleeve gastrectomy
    Silvana Perretta, University of Strausbourg, France
  4. Revision options after weight loss failure
    TBD

Video Symposium 4

Lessons from Problematic Situations (Intra- and Post-Operative Complications)

Please join in the Video Contest (Click)

Date & Time April 13 (Sat), 08:30-10:00 Venue Room C
Chairs TBD
Speaker
  1. Management for Massive bleeding situation
    TBD
  2. Chaos situation occurred during 12a lymph node dissection
    TBD
  3. Handling of staple malfunction
    TBD
  4. When and how to perform re-operation for post-operative leakage
    TBD
  5. Common intra-operative problems with chronic alcoholic patients.
    TBD

Symposium 19 (KLASS sy 2)

Excellent Tips for Safe Laparoscopic Gastrectomy: Video Session

In this KLASS video session, safe duodenal stump manipulation and gastro-duodenostomy will be introduced. Combined organ resection and dealing with serosa-positive cancer during laparoscopic gastrectomy will be displayed.

Date & Time April 13 (Sat), 08:30-10:00 Venue Room D
Chairs TBD
Speaker
  1. Duodenal stump manipulation
    TBD
  2. Gastro-duodenostomy
    TBD
  3. Combined organ resection for far advanced cancer (pancreas, T-colon, spleen, and liver)
    TBD
  4. Dealing with serosa-positive cancer
    TBD

Presidential Lecture

Date & Time April 13 (Sat), 12:00-12:30 Venue Room A
Chairs TBD
Speaker TBD
Byung-sik Kim, University of Ulsan, Korea